Google Alert - finance

	finance As-it-happens update ⋅ April 27, 2023
	NEWS
	NPR Eli Lilly releases more data for new obesity drug, moving toward fast-track approval NPR Tirzepatide, marketed as Mounjaro for diabetes, showed even higher levels of weight loss: Participants had lost about 21% of their body weight, which was unprecedented. The drug is already approved as an injectable ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback